Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis. | Nat Commun | 2023 | 37080973 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| Heterogeneous pattern of gene expression driven by TTN mutation is involved in the construction of a prognosis model of lung squamous cell carcinoma. | Front Oncol | 2023 | 37035196 | PubTator, text mining | PubMed |
| Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma. | Front Oncol | 2023 | 37035149 | PubTator, text mining | PubMed |
| Identification of anoikis-related genes classification patterns and immune infiltration characterization in ischemic stroke based on machine learning. | Front Aging Neurosci | 2023 | 37032832 | PubTator, text mining | PubMed |
| Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer. | Nat Commun | 2023 | 37031202 | PubTator, text mining | PubMed |
| Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study. | Lupus Sci Med | 2023 | 37012057 | PubTator, text mining | PubMed |
| Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC. | Med Oncol | 2023 | 37010645 | PubTator, text mining | PubMed |
| Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma. | Precis Clin Med | 2023 | 37007745 | PubTator, text mining | PubMed |
| Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers. | Front Immunol | 2023 | 37006265 | PubTator, text mining | PubMed |
| Modic type 2 changes are fibroinflammatory changes with complement system involvement adjacent to degenerated vertebral endplates. | JOR Spine | 2023 | 36994463 | PubTator, text mining | PubMed |
| First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors. | J Exp Clin Cancer Res | 2023 | 36991390 | PubTator, text mining | PubMed |
| Ph-Positive B-Cell Acute Lymphoblastic Leukemia Occurring after Receipt of Bivalent SARS-CoV-2 mRNA Vaccine Booster: A Case Report. | Medicina (Kaunas) | 2023 | 36984629 | PubTator, text mining | PubMed |
| Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review. | Int J Surg | 2023 | 36974713 | PubTator, text mining | PubMed |
| Exploring the components and mechanism of Solanum nigrum L. for colon cancer treatment based on network pharmacology and molecular docking. | Front Oncol | 2023 | 36969029 | PubTator, text mining | PubMed |
| Adherent-invasive Escherichia coli associated with granulomatous colitis and extraintestinal dissemination in a Sphynx cat. | Vet Pathol | 2023 | 36951102 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of normal and pathological tissues from the same patient uncovers colon cancer progression. | Cell Biosci | 2023 | 36944972 | PubTator, text mining | PubMed |
| Specific gene expression signatures of low grade meningiomas. | Front Oncol | 2023 | 36937440 | PubTator, text mining | PubMed |
| Digital spatial profiling of intraductal papillary mucinous neoplasms: Toward a molecular framework for risk stratification. | Sci Adv | 2023 | 36930707 | PubTator, text mining | PubMed |
| Screening of potential immune-related genes expressed during sepsis using gene sequencing technology. | Sci Rep | 2023 | 36918563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=15